Alx Oncology Holdings (ALXO) EPS (Basic) (2019 - 2026)
Alx Oncology Holdings (ALXO) posted EPS (Basic) of -$0.21 for Q1 2026, up 51.41% sequentially from -$0.43 in Q4 2025, and up 64.12% YoY from -$0.13 in Q1 2025.
Powered by 
Analysis
Alx Oncology Holdings (ALXO) EPS (Basic) (2019 - 2026) Analysis & Trends
Alx Oncology Holdings has reported EPS (Basic) for 8 years, with the latest figure at -$0.21 in Q1 2026.
- Quarterly EPS (Basic) rose 64.12% year-over-year to -$0.21 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.92 (up 63.19% YoY) and the FY2025 annual result came in at -$0.01, up 99.55% from the prior year.
- EPS (Basic) advanced to -$0.21 in Q1 2026 per ALXO's latest filing, from -$0.43 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.21 in Q1 2026 and troughed at -$1.24 in Q3 2023.
- A 5-year average of -$0.7 and a median of -$0.75 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2026: EPS (Basic) tumbled 109.34% in 2022, then soared 64.12% in 2026.
- Over 5 years, EPS (Basic) stood at -$0.75 in 2022, then plunged by 41.08% to -$1.06 in 2023, then soared by 47.36% to -$0.56 in 2024, then increased by 23.91% to -$0.43 in 2025, then jumped by 51.41% to -$0.21 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.21, -$0.43, and -$0.41 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | 0.18 |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -0.06 |
| 10 | Alx Oncology Holdings | 273.99 Mn | 273.99 Mn | - | -0.12 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.12 |
| Mar 31, 2026 | -0.19 |
| Dec 31, 2025 | -0.43 |
| Sep 30, 2025 | -0.41 |
| Jun 30, 2025 | -0.49 |
| Mar 31, 2025 | -0.61 |
| Dec 31, 2024 | -0.56 |
| Sep 30, 2024 | -0.58 |
| Jun 30, 2024 | -0.81 |
| Mar 31, 2024 | -0.77 |
| Dec 31, 2023 | -1.06 |
| Sep 30, 2023 | -1.24 |
| Jun 30, 2023 | -0.91 |
| Mar 31, 2023 | -0.78 |
| Dec 31, 2022 | -0.75 |
| Sep 30, 2022 | -0.87 |
| Jun 30, 2022 | -0.85 |
| Mar 31, 2022 | -0.62 |
| Dec 31, 2021 | -0.71 |
| Sep 30, 2021 | -0.61 |